| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 04/27/2006 | WO2006043036A2 Treatment of diabetes |
| 04/27/2006 | WO2006042955A1 Pyridine derivatives and the preparation and the therapeutic use thereof |
| 04/27/2006 | WO2006042954A1 2-amido-4-phenylthiazole derivatives, the preparation and the therapeutic use thereof |
| 04/27/2006 | WO2006042950A2 Use of pyrrolopyrazine derivatives for the production of medicaments for the treatment of mucoviscidosis and diseases related to protein addressing errors in cells |
| 04/27/2006 | WO2006042949A1 Use of purine derivatives for the production of medicaments for the treatment of mucoviscidosis and diseases related to protein addressing errors in cells |
| 04/27/2006 | WO2006042948A1 Use of paullone derivatives for the production of medicaments for the treatment of mucoviscidosis and diseases related to protein addressing errors in cells |
| 04/27/2006 | WO2006042909A1 Nutrient supplement and use of the same |
| 04/27/2006 | WO2006042890A1 Therapeutic composition for the treatment of burns |
| 04/27/2006 | WO2006042858A2 Complex comprising an antibiotic, a cyclodextrin and an interaction agent |
| 04/27/2006 | WO2006042857A2 Complex containing mequitazine, a cyclodextrin and an interaction agent |
| 04/27/2006 | WO2006042850A1 Cyanothiophenes, the production thereof and their use as medicaments |
| 04/27/2006 | WO2006042733A2 Methods of using fatty-acid esters of estrogens and thermogenic compounds for reducing the body weight of a mammal and compositions containing the same |
| 04/27/2006 | WO2006042732A1 Methods of using fatty-acid esters of estrogens and serotonin reuptake inhibiting compounds for reducing the body weight of a mamal and compositions containing the same |
| 04/27/2006 | WO2006042728A2 Use of stable ammonium liponate salts for the treatment of diabetic and other disorders |
| 04/27/2006 | WO2006042679A1 Use of a beta-3 agonist for treating complaints of the prostate and the lower urogenital tract |
| 04/27/2006 | WO2006042666A1 R-(+)-α-LIPONIC ACID FOR THE PREVENTION OF DIABETES |
| 04/27/2006 | WO2006042662A1 Parenteral forms of administration of imexon and method for the production thereof |
| 04/27/2006 | WO2006042638A1 3,6-substituted 5-arylamino-1h-pyidine-2-one derivatives and related compounds as poly(adp-ribose)polymerase (parp) inhibitors in the treatment of tissue damage or disease caused by necrosis or apoptosis |
| 04/27/2006 | WO2006042634A1 4-aminophenyl morpholinone derivatives for the treatment of hepatitis c |
| 04/27/2006 | WO2006042599A1 Phenylurea derivatives used as inhibitors of tyrosinkinase for treating tumors |
| 04/27/2006 | WO2006042481A1 Method of obtaining clopidogrel |
| 04/27/2006 | WO2006042479A1 Pharmaceutical composition and non dependence coffee comprising edible carboxylic acid and/or its acid salt and coffeine |
| 04/27/2006 | WO2006042478A1 Small-molecule inhibitors of coronaviral main protease, their preparation and use |
| 04/27/2006 | WO2006042454A1 Puerarin derivatives and their medical uses |
| 04/27/2006 | WO2006042418A1 Antiviral oligonucleotides |
| 04/27/2006 | WO2006042409A1 Sex steroid precursors alone or in combination with a selective estrogen receptor modulator and/or with estrogens and/or a type 5 cgmp phosphodiesterase inhibitor for the prevention and treatment of vaginal dryness and sexual dysfunction in postmenopausal women |
| 04/27/2006 | WO2006042406A1 Method for modification of ϝ-secretase activity through inhibition of fkbp13 |
| 04/27/2006 | WO2006042403A1 Process for producing natural immunobiotic extract and uses thereof |
| 04/27/2006 | WO2006042396A1 Modulation of neuroglia-derived bdnf in the treatment and prevention of pain |
| 04/27/2006 | WO2006042389A1 Hydroalcoholic extract of erythrina mulungu, pharmaceutical compositions and processes for producing these substances |
| 04/27/2006 | WO2006042387A1 Drugs derived from diclofenac containing no-donor heterocycles, composition and method of inflammation treatment |
| 04/27/2006 | WO2006042383A1 Vitamin-d analogue useful in a pharmaceutical composition |
| 04/27/2006 | WO2006042370A1 Hair and nail compositions and methods |
| 04/27/2006 | WO2006042362A1 Use of 4-(4-methylpiperazin-1-ylmethyl)-n-[4-methyl-3-(4-(pyridin-3-yl)pyrimidin-2-ylamino)phenyl]-benzamide to inhibit the tyrosine kinase receptor c-fms |
| 04/27/2006 | WO2006029146A3 6H-[1]BENZOPYRANO[4,3-b]QUINOLINES AND THEIR USE AS ESTROGENIC AGENTS |
| 04/27/2006 | WO2006028896A3 Chemical compounds |
| 04/27/2006 | WO2006027786A3 Use of liposomal glucocorticoids for treating inflammatory states |
| 04/27/2006 | WO2006027545A3 Method |
| 04/27/2006 | WO2006025069A3 Tricyclic pyrazole derivatives as cannabinoid receptor modulators |
| 04/27/2006 | WO2006021660A8 Use of at least one conjugated triene-containing fatty acid for preparing a medicine for treating inflammation |
| 04/27/2006 | WO2006021412A3 Use of peptide compounds for treating bone cancer pain, chemotherapy-and nucleoside-induced pain |
| 04/27/2006 | WO2006021379A8 Dihydropteridinone derivatives, methods for the production thereof and their use as medicaments |
| 04/27/2006 | WO2006021378A8 Dihydropteridinone derivatives, methods for the production thereof and their use as medicaments |
| 04/27/2006 | WO2006017627A3 Dietary compositions comprising docosahexaenoic acid and eicosapentaenoic acid and use thereof for treating insulin resistance |
| 04/27/2006 | WO2006015382A3 Integrin alpha-v beta-3 antagonists for use in imaging and therapy |
| 04/27/2006 | WO2006014290A3 Anti-inflammatory medicaments |
| 04/27/2006 | WO2006013445A3 Thiazolidinedione derivatives as alpha adrenergic receptor antagonists |
| 04/27/2006 | WO2006012256A3 Fkbp binding composition and pharmaceutical use thereof |
| 04/27/2006 | WO2006010009A3 Hyaluronic acid in the enhancement of lens regeneration |
| 04/27/2006 | WO2006008757A3 Stabilized pharmaceutical compositions of pravastatin |
| 04/27/2006 | WO2006007528A9 Lxr/rxr-related methods and compositions |
| 04/27/2006 | WO2006007354A3 A drug/polymer complex, preferably ciprofloxacin/hpmc, its method of manufacturing using lyophilization and its use in an osmotic device |
| 04/27/2006 | WO2006005507A3 Pharmaceutical composition of piperazine derivatives |
| 04/27/2006 | WO2006002927A3 Medium chain fatty acids applicable as anti-microbial agents |
| 04/27/2006 | WO2006000371A3 Pyrimidine derivatives as 11beta-hsd1 inhibitors |
| 04/27/2006 | WO2005123134A3 A controlled release delivery system for metformin |
| 04/27/2006 | WO2005120512A3 Cancer treatment method |
| 04/27/2006 | WO2005118564A3 Methods for the synthesis of milnacipran and congeners thereof |
| 04/27/2006 | WO2005117909A3 Kinase modulators and methods of use |
| 04/27/2006 | WO2005117870A3 Combination of proton pump inhibitor, buffering agent, and prokinetic agent |
| 04/27/2006 | WO2005117848A9 Vascular targets for detecting, imaging and treating neoplasia or neovasculature |
| 04/27/2006 | WO2005117829A3 Chewable, suckable and swallowable tablet containing a calcium-containing compound as an active substance |
| 04/27/2006 | WO2005115359A3 Methods and compositions for the treatment of uveitis |
| 04/27/2006 | WO2005113586A3 Disease-associated proteins |
| 04/27/2006 | WO2005110985A3 Indole, benzofuran and benzothiophene derivatives as selective androgen receptor modulators (sarms) |
| 04/27/2006 | WO2005105159A3 Contrast agents for myocardial perfusion imaging |
| 04/27/2006 | WO2005105067A3 Aqueous solutions comprising prednisolone and a cyclodextrin derivative |
| 04/27/2006 | WO2005102296A3 Combinations for the treatment of immunoproliferative skin disorders such as psoriasis |
| 04/27/2006 | WO2005101004A3 Diagnostics and therapeutics for diseases associated with purinoceptor 1 type y (p2y1) |
| 04/27/2006 | WO2005097729A3 Method for the synthesis of quaternary ammonium compounds and compositions thereof |
| 04/27/2006 | WO2005097111A3 Treatment of tremor with histamine h3 inverse agonists or histamine h3 antagonists |
| 04/27/2006 | WO2005094457A3 Novel anti-arrhythmic and heart failure drugs that target the leak in the ryanodine receptor (ryr2) and uses thereof |
| 04/27/2006 | WO2005092907A3 Monosaccharide derivatives as anti-cancer and anti-inflammatory agents |
| 04/27/2006 | WO2005090320A3 Triazole derivatives and method of using the same to treat hiv infections |
| 04/27/2006 | WO2005089515A3 Methods for the treatment of synucleinopathies |
| 04/27/2006 | WO2005079815A3 Methods and reagents for treating autosomal dominant diseases of the eye |
| 04/27/2006 | WO2005077462A3 Cd70 inhibition for the treatment and prevention of inflammatory bowel disease |
| 04/27/2006 | WO2005065712A3 Complexes having adjuvant activity |
| 04/27/2006 | WO2005065641A3 Non-disintegrating oral solid composition of high dose of water soluble drugs |
| 04/27/2006 | WO2005065047A3 Stable oral composition containing desloratadine |
| 04/27/2006 | WO2005053689A3 Pharmaceutical compositions comprising lercanidipine |
| 04/27/2006 | WO2005051404A8 Pharmaceutical composition for the treatment of cardiovascular and cerebrovascular diseases |
| 04/27/2006 | WO2005051348A3 Enteric-coated tablets of pantoprazole |
| 04/27/2006 | WO2005027903A8 Polyether brevetoxin derivatives as a treatment for neurotoxic shellfish poisoning and ciguatera fish poisoning |
| 04/27/2006 | WO2005027884A3 Stabilized ocular solutions |
| 04/27/2006 | WO2005020909A3 Cellular depolarization and regulation of matrix metalloproteinases |
| 04/27/2006 | WO2004112705A3 Methods for treating sleep disorders |
| 04/27/2006 | WO2004105773A3 Use of s1p |
| 04/27/2006 | WO2004098517A3 Methods of hormonal treatment utilizing extended cycle contraceptive regimens |
| 04/27/2006 | WO2004087072A3 Topical l-carnitine compositions |
| 04/27/2006 | WO2004021992A3 Delivery of therapeutics to the brain and spinal cord |
| 04/27/2006 | WO2003040333A3 Methods for inhibiting proliferation of astrocytes and astrocytic tumor cells and for enhancing survival of neurons and uses thereof |
| 04/27/2006 | US20060089500 Beta-aryl-alpha-oxysubstituted alkylcarboxylic acids; antiobesity and hypocholesterolemic compounds |
| 04/27/2006 | US20060089498 3-amino-2-ethoxycarbonylpyrrole; chemical intermediate in synthesis of 3H,5H-pyrrolo[3,2-d]pyrimidin-4-one; a convergent synthesis route rather than a linear one |
| 04/27/2006 | US20060089497 Benzenesulphonate salt of a morpholine urea derivative for use as a ccr-3 antagonist in the treatment of inflammatory conditions |
| 04/27/2006 | US20060089478 Organosilicon fine particles and method of producing same |
| 04/27/2006 | US20060089415 Anti-infective agents and methods of use |
| 04/27/2006 | US20060089414 Generic probes for the detection of phosphorylated sequences |
| 04/27/2006 | US20060089413 Anthranilic acid amides and derivatives thereof as cosmetic and pharmaceutical agents |
| 04/27/2006 | US20060089412 Pharmaceutical composition for the treatment of non-alcoholic fatty liver disease |